Analysts expect that UnitedHealth Group Inc (NYSE:UNH) will post sales of $59.66 billion for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for UnitedHealth Group’s earnings, with estimates ranging from $59.47 billion to $59.92 billion. UnitedHealth Group reported sales of $55.19 billion during the same quarter last year, which would indicate a positive year over year growth rate of 8.1%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, April 16th.
On average, analysts expect that UnitedHealth Group will report full-year sales of $244.23 billion for the current year, with estimates ranging from $243.42 billion to $244.91 billion. For the next fiscal year, analysts forecast that the company will post sales of $264.00 billion, with estimates ranging from $261.21 billion to $266.54 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 EPS for the quarter, topping the Zacks’ consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $58.42 billion for the quarter, compared to analysts’ expectations of $58.01 billion. During the same quarter last year, the business earned $2.59 earnings per share. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Thursday, January 17th. The stock was sold at an average price of $260.55, for a total value of $3,908,250.00. Following the transaction, the director now directly owns 193,872 shares in the company, valued at approximately $50,513,349.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 6,090 shares of the company’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total value of $1,715,674.80. Following the completion of the transaction, the director now owns 1,711,584 shares in the company, valued at $482,187,444.48. The disclosure for this sale can be found here. Insiders have sold 26,090 shares of company stock valued at $6,956,975 in the last quarter. 0.87% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the company. TIAA CREF Investment Management LLC boosted its holdings in UnitedHealth Group by 7.3% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after acquiring an additional 370,179 shares during the period. Financial Enhancement Group LLC lifted its holdings in UnitedHealth Group by 2,579.3% in the 3rd quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock worth $413,000 after buying an additional 1,496 shares during the period. BLB&B Advisors LLC lifted its holdings in UnitedHealth Group by 5.8% in the 4th quarter. BLB&B Advisors LLC now owns 1,198 shares of the healthcare conglomerate’s stock worth $298,000 after buying an additional 66 shares during the period. Sawtooth Solutions LLC lifted its holdings in UnitedHealth Group by 34.4% in the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after buying an additional 1,129 shares during the period. Finally, Bluefin Trading LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $578,000. Hedge funds and other institutional investors own 90.80% of the company’s stock.
Shares of UnitedHealth Group stock traded up $5.80 during midday trading on Thursday, reaching $271.13. The company had a trading volume of 3,673,506 shares, compared to its average volume of 3,821,493. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.69. The firm has a market cap of $260.16 billion, a P/E ratio of 21.05, a P/E/G ratio of 1.35 and a beta of 0.86. UnitedHealth Group has a fifty-two week low of $212.49 and a fifty-two week high of $287.94.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is the NASDAQ?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.